Search results
Results from the WOW.Com Content Network
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
It then acquired a respiratory treatment product, and an infant skincare brand from Dr. Reddy's Laboratories. It also bought a majority stake in the Ayurvedic and herbal products manufacturer, Upakarma Ayurveda. In 2022, the company entered agritech and pet care segments.
G. V. Prasad (son-in-law) Kallam Anji Reddy (10 August 1941 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996.
Dr. Reddy's Laboratories (NYS: RDY) reported earnings on May 11.Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q4), Dr. Reddy's Laboratories beat ...
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.
Kallam Satish Reddy is an Indian business executive and current Chairman of Dr. Reddy's Laboratories. [2] [3] Reddy joined Dr. Reddy's Laboratories in 1993 as executive director. Elevated to the role of Managing Director in 1997, he led the company's transition from a manufacturer of active pharmaceutical ingredients to one with a diverse ...
He is widely credited [by whom?] as the architect of Dr. Reddy's successful global generics strategy. He envisioned newer business platforms like the Custom Pharmaceutical business and Specialty pharmaceuticals and is dedicated to building the innovation side of the business.
Jeffrey Aubé. Dumbala Srinivasa Reddy (born 1971) is currently Director CSIR-IICT Indian Institute of Chemical Technology [1] Hyderabad India (June 2022), he has additional charge of CSIR-IIIM CSIR-Institute of Integrative Medicine [2] at Jammu and CSIR-CDRI CSIR-Drug Research Institute [3] at Lucknow, India. CSIR-IICT Hyderabad India.
Key people. Dr Vamsi Krishna Reddy Bandi. Number of employees. Over 22,000. Website. www.hetero.com. Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.
In November 2014, UCB announced its intention to sell off its generics subsidiary (Kremers Urban Pharmaceuticals) for more than $1.5 billion to two private equity firms. In 2015, UCB announced the sale of its branded generics business in India and South Asia to Dr. Reddy's Laboratories for INR 8 billion ($128.38 million).